Covidien in its acquisition of SuperDimension
Meitar represented Covidien, a U.S. medical device manufacturer, in its acquisition of SuperDimension, an Israeli company with a cutting-edge technology for minimally-invasive surgical procedures on the lungs, for $300 million in cash, with future earn out payments possible. The transaction is expected to be completed during the second quarter of 2012.